Hong Li

Chief Executive Officer at

Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd.

59 year

Health Technology

Profile

Presently, Hong Li is General Manager & Executive Director of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

Companies	Position	Start
Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. is a modern pharmaceutical company with extensive experience in drug research, production, and sales. The company is based in Guangzhou, China. Its product portfolio includes powder injections, small-volume injections, oral solid preparations, antibiotics, and cardiovascular drugs. The Chinese company participates in national procurement projects and quality evaluations, focusing on research and development, market expansion, and brand building to support public health.	Chief Executive Officer	-

Companies	Position	End
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED	Chief Executive Officer	29/05/2026
Guangzhou Baiyunshan Qiaoguang Pharmaceutical Co. Ltd. Guangzhou Baiyunshan Qiaoguang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Chairman	-

Active

Inactive

Listed companies

Private companies

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

Private companies	3
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes traditional Chinese medicines	Health Technology
Guangzhou Baiyunshan Qiaoguang Pharmaceutical Co. Ltd. Guangzhou Baiyunshan Qiaoguang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical products	Health Technology
Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. Guangzhou Baiyunshan Tian Xin Pharmaceutical Co., Ltd. is a modern pharmaceutical company with extensive experience in drug research, production, and sales. The company is based in Guangzhou, China. Its product portfolio includes powder injections, small-volume injections, oral solid preparations, antibiotics, and cardiovascular drugs. The Chinese company participates in national procurement projects and quality evaluations, focusing on research and development, market expansion, and brand building to support public health.